ConductScience.org, home

Paper39174604

Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).

Tsujinaka H and 13 others. Sci Rep, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST). Papers, record 39174604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39174604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).
PubMed
Journal
Sci Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
2.22, provisional
iCite
Revised in PubMed
2025-01-02
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tsujinaka HHiroki
2Imoto SSho
3Ueda TTetsuo
4Wakuta MMakiko
5Yamada YYutaka
6Sugisawa TTakaaki
7Murao FFumiko
8Hirano TTakao
9Yoshida SShigeo
10Kato KKumiko
11Sasaki MMariko
12Matsumoto RRiko
13Ishigooka GGaku
14Ogata NNahoko

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Macular EdemaMajor topic
TaxoidsMajor topic
Visual AcuityMajor topic
Humans
Female
Male
Aged
Retrospective Studies
Japan
Middle Aged
Incidence
Prognosis
Bridged-Ring Compounds
Aged, 80 and over
Antineoplastic Agents
Docetaxel
Paclitaxel
Retina

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130156164Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory.Curr Drug Saf2019https://conductscience.org/library/papers/30156164PubMed
225170855Choroidal thickness in clinically significant pseudophakic cystoid macular edema.Retina2015https://conductscience.org/library/papers/25170855PubMed
328868019Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review.Case Rep Oncol2017https://conductscience.org/library/papers/28868019PubMed
423154489Topical dorzolamide therapy for taxane-related macular oedema.Eye (Lond)2013https://conductscience.org/library/papers/23154489PubMed
535857057Nab-Paclitaxel related cystoid macular edema.Clin Ter2022https://conductscience.org/library/papers/35857057PubMed
623061416Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.J Ocul Pharmacol Ther2013https://conductscience.org/library/papers/23061416PubMed
737434856A meta-analysis of the incidence and risk of skin toxicity with nab-paclitaxel and paclitaxel in cancer treatment.Am J Transl Res2023https://conductscience.org/library/papers/37434856PubMed
810071301Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death.J Clin Oncol1999https://conductscience.org/library/papers/10071301PubMed
924564293Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report.BMC Ophthalmol2014https://conductscience.org/library/papers/24564293PubMed
109402182Ophthalmic toxicity following paclitaxel infusion.Ann Oncol1997https://conductscience.org/library/papers/9402182PubMed
115553076Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.J Am Chem Soc1971https://conductscience.org/library/papers/5553076PubMed
1222592399Cystoid macular edema induced by nab-paclitaxel.Breast Cancer2015https://conductscience.org/library/papers/22592399PubMed
1330381669Risk Factors for Eye Disorders Caused by Paclitaxel: A Retrospective Study.Biol Pharm Bull2018https://conductscience.org/library/papers/30381669PubMed
1419668445Cystoid macular edema.Clin Ophthalmol2008https://conductscience.org/library/papers/19668445PubMed
1525764317Cystoid macular edema and macular pigmentation associated with nab-Paclitaxel therapy.Retin Cases Brief Rep2015https://conductscience.org/library/papers/25764317PubMed
169205828The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication.Br J Clin Pharmacol1997https://conductscience.org/library/papers/9205828PubMed
1731112878Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis.Crit Rev Oncol Hematol2019https://conductscience.org/library/papers/31112878PubMed
1831755455Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema.Indian J Ophthalmol2019https://conductscience.org/library/papers/31755455PubMed
1935951320Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.JAMA Ophthalmol2022https://conductscience.org/library/papers/35951320PubMed
2019001234Cystoid macular edema secondary to albumin-bound paclitaxel therapy.Arch Ophthalmol2008https://conductscience.org/library/papers/19001234PubMed

See all 21 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42559568Nab-Paclitaxel-Induced Cystoid Macular Edema with Minimal Fluorescein Leakage: A Case Report of Two Patients from a Tertiary Referral Center.Case Rep Ophthalmol2026https://conductscience.org/library/papers/42559568PubMed
42525694Real‑world analysis of Macular Oedema associated with Paclitaxel Formulations using the Japanese Adverse Drug Event Report database.PLoS One2026https://conductscience.org/library/papers/42525694PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39174604

GET https://conductscience.org/api/papers/v1/39174604/references?page=2